Wave Life Sciences (NASDAQ:WVE) Given “Buy” Rating at HC Wainwright
HC Wainwright reiterated their buy rating on shares of Wave Life Sciences (NASDAQ:WVE – Free Report) in a research note issued to investors on Thursday, Benzinga reports. The firm currently has a $22.00 price target on the stock. A number of other equities research analysts have also issued reports on WVE. B. Riley increased their […]
1 Nov 16:22 · The Markets Daily